Feb 24, 2021 / 10:00PM GMT
Operator
Thank you for standing by and welcome to the Imricor Medical Systems Inc. FY 2020 results investor briefing. (Operator Instructions)
I would now like to hand the conference over to Mr. Steve Wedan, Chair and CEO. Please go ahead.
Steve Wedan - Imricor Medical Systems, Inc. - CEO, President & Executive Chairman
Thanks. Hello, everyone. Thank you for joining us today to discuss the full year results for Imricor. I'm Steve Wedan, Imricor's Chair and CEO, and I'm joined today by our CFO, Lori Milbrandt. Today, I'll take you through Imricor's key achievements during 2020 and discuss the current COVID situation in Europe and our expectations around our lab rollout plan. We will also provide you with an update on progress we've made across other growth strategies that are positioning us for an exciting year in 2021. Lori will then discuss the financial results for the year before I take you through our outlook. We'll then move to a Q&A session.
As shown on Slide 5, we started 2020 in an exciting position, achieving an long-awaiting CE mark
Full Year 2020 Imricor Medical Systems Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot